YIKA, has successfully completed 6- and 9-month ethics committee-approved case analyzes in a state and a university hospital. Continuing its work with the support of TÜBİTAK TEYDEB 1501 and the seed investment it received last February, ERG Controls continues to popularize its product YIKA in the country’s leading healthcare institutions.
